Christophe Erneux currently works at (IRIBHM), Universite Libre de Bruxelles in Belgium on phosphoinositide signaling in cancer. The most recent publication is Uzureau et al Cell Reports 2020. Christophe Erneux interest in phosphoinositides originated in the cloning of inositol polyphosphate 5-phosphatase (INPP5A), Ins(1,4,5)P3 3-kinases a, b and c (the enzymes that phosphorylate Ins(1,4,5)P3 to Ins(1,3,4,5)P4), and the SH2 domain containing inositol 5-phosphatases SHIP1 and SHIP2.